World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 3184165

Number of visits today: 248

Number of downloads: 2347007

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons. Clin Infect Dis 2021;73:816-23. [PMID: 33605977 DOI: 10.1093/cid/ciab152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]

For:

Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons. Clin Infect Dis 2021;73:816-23. [PMID: 33605977 DOI: 10.1093/cid/ciab152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]

Number	Citing Articles
1	Gärtner BC, Weinke T, Wahle K, Kwetkat A, Beier D, Schmidt KJ, Schwarz TF. Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data. Vaccine 2022:S0264-410X(22)00440-6. [PMID: 35459556 DOI: 10.1016/j.vaccine.2022.04.019] [Reference Citation Analysis]
2	Boikos C, Imran M, Nguyen VH, Ducruet T, Sylvester GC, Mansi JA. Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications. Vaccines (Basel) 2021;9:862. [PMID: 34451987 DOI: 10.3390/vaccines9080862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3	Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Reference Citation Analysis]
4	Boikos C, Imran M, De Lusignan S, Ortiz JR, Patriarca PA, Mansi JA. Integrating Electronic Medical Records and Claims Data for Influenza Vaccine Research. Vaccines 2022;10:727. [DOI: 10.3390/vaccines10050727] [Reference Citation Analysis]
5	Kwetkat A, Heppner HJ, Endres AS, Leischker A. [Influenza]. Internist (Berl) 2021;62:801-6. [PMID: 34236439 DOI: 10.1007/s00108-021-01101-1] [Reference Citation Analysis]
6	Loiacono MM, Van Aalst R, Pokutnaya D, Mahmud SM, Nealon J. Methods to account for measured and unmeasured confounders in influenza relative vaccine effectiveness studies: A brief review of the literature. Influenza Other Respir Viruses 2022. [PMID: 35545260 DOI: 10.1111/irv.12999] [Reference Citation Analysis]